Olwen Hahn to Benzimidazoles
This is a "connection" page, showing publications Olwen Hahn has written about Benzimidazoles.
Connection Strength
0.050
-
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer. J Oncol Pharm Pract. 2026 Jun; 32(4):641-647.
Score: 0.050